These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death. Holland K; Patterson E; Lucchesi BR Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113 [TBL] [Abstract][Full Text] [Related]
5. Mechanism of the positive inotropic responses to bretylium and guanethidine. BHAGAT B; SHIDEMAN FE Br J Pharmacol Chemother; 1963 Feb; 20(1):56-62. PubMed ID: 13967966 [TBL] [Abstract][Full Text] [Related]
9. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex. Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357 [TBL] [Abstract][Full Text] [Related]
10. Comparison of bretylium tosylate and lidocaine in management of out of hospital ventricular fibrillation: a randomized clinical trial. Haynes RE; Chinn TL; Copass MK; Cobb LA Am J Cardiol; 1981 Aug; 48(2):353-6. PubMed ID: 7023224 [TBL] [Abstract][Full Text] [Related]
11. Effect of bretylium on neuromuscular transmission. Welch GW; Waud BE Anesth Analg; 1982 May; 61(5):442-4. PubMed ID: 6278989 [TBL] [Abstract][Full Text] [Related]
12. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey. Puddu PE; Jouve R; Saadjian A; Torresani J J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968 [TBL] [Abstract][Full Text] [Related]
13. Inactivation of acetylcholinesterase with a bretylium tosylate photoaffinity probe. Branchini BR; Lajiness EJ Biochim Biophys Acta; 1986 Oct; 884(1):135-41. PubMed ID: 3768408 [TBL] [Abstract][Full Text] [Related]
14. Bretylium: a prototype for future development of antidysrhythmic agents. Patterson E; Lucchesi BR Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235 [No Abstract] [Full Text] [Related]
15. THE SYMPATHETIC POSTGANGLIONIC FIBRE AND THE BLOCK BY BRETYLIUM; THE BLOCK PREVENTED BY HEXAMETHONIUM AND IMITATED BY MECAMYLAMINE. BURN JH; GIBBONS WR Br J Pharmacol Chemother; 1964 Jun; 22(3):549-57. PubMed ID: 14211685 [TBL] [Abstract][Full Text] [Related]
16. Cardiac arrhythmias produced by bretylium in cats anesthetized with halothane. Condouris GA; Ortiz J; Lyness W Eur J Pharmacol; 1979 Apr; 55(1):93-7. PubMed ID: 35358 [TBL] [Abstract][Full Text] [Related]
17. Clinical suppression of refractory ventricular tachycardia with oral bretylium not predicted by electrophysiologic drug testing. Grubb BP; Luck JC; Bacaner M Chest; 1988 Aug; 94(2):430-2. PubMed ID: 3396427 [TBL] [Abstract][Full Text] [Related]
18. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle. Breznock EM; Kagan K; Hibser NK Am J Vet Res; 1977 Jan; 38(1):89-94. PubMed ID: 835872 [TBL] [Abstract][Full Text] [Related]
19. Bretylium tosylate in the management of recurrent ventricular fibrillation complicating acute myocardial infarction. Dhurandhar RW; Pickron J; Goldman AM Heart Lung; 1980; 9(2):265-70. PubMed ID: 6898604 [TBL] [Abstract][Full Text] [Related]
20. Electrophysiologic testing of bretylium tosylate in sustained ventricular tachycardia. Bauernfeind RA; Hoff JV; Swiryn S; Palileo E; Strasberg B; Scagliotti D; Rosen KM Am Heart J; 1983 Jun; 105(6):973-80. PubMed ID: 6858846 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]